Viral immunology is a specialized field of study that investigates the host immune responses to viral infections and the mechanisms viruses employ to evade or manipulate the immune system. The complex interplay between viruses and the host immune system involves intricate cellular and molecular interactions. In viral immunology, researchers examine how the innate and adaptive immune responses recognize and combat viral invaders. Key components include the identification of viral antigens, the activation of immune cells like T cells and B cells, and the production of antiviral antibodies. Understanding viral immunology is essential for vaccine development, as vaccines leverage the immune system's ability to recognize and remember viral threats. Additionally, research in this field contributes to antiviral drug development, aiming to disrupt viral replication without compromising the host's immune function. Viral immunology also explores the concept of immunoevasion, where viruses employ strategies to subvert or evade immune surveillance. Ongoing advancements in this field contribute to our ability to design effective interventions to prevent and treat viral infections.
Title : A promising novel approach to DNA vaccines
Khursheed Nadeem Anwer, IMUNON, United States
Title : Nanoscopic SubATVax™ adjuvanted vaccines against influenza A types H3N2, H1N1 and influenza type B for subcutaneous administration
David Craig Wright, D4 Labs, LLC, United States
Title : The importance of post-marketing surveillance and real-world data for a product to be successful
Regina Au, BioMarketing Insight, United States
Title : Prophylactic and molecular approaches for mitigating human influenza A viruses: i. Evaluating influenza vaccine effectiveness in the older population ii. Down-regulation of influenza virus genes with novel sirna-chimeric-ribozyme constructs
Madhu Khanna, University of Delhi, India
Title : Commensal bacteria drive B-cell lymphomagenesis in the setting of innate immunodeficiency
Ping Xie, Rutgers University, United States
Title : The role of immunity in the pathogenesis of SARS-COV-2 and in the protection generated by COVID-19 in different age groups
Ahmed Abdulazeez, BHRUT Trust, United Kingdom
Title : Establishing a platform method for physical appearance assessment of new parenteral pharmaceuticals
Ying Wan, Merck & Co., United States
Title : Evaluating the immunogenic impact of process impurities in mRNA vaccine production: Establishing integrated control strategies and specifications
Jesse Kuiper, Merck Research Laboratories, United States
Title : New biomarkers in leishmania major vaccine development
Negar Seyed, Pasteur Institute of Iran, Iran (Islamic Republic of)
Title : Advances in vaccines: Revolutionizing disease prevention
Delia Teresa Sponza, Dokuz Eylul University, Turkey